Larvol Delta - A-Study-to-Test-BI-764198-in-People-With-a-Type-of-Kidney-Disease-Called-Primary-Focal-Segmental-Glomerulosclerosis

apecotrep (BI 764198) - Boehringer Ingelheim, Aurobac Therapeutics

http://clinicaltrials.gov/ct2/show/NCT05213624

Jul 26, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next